[Expert consensus on the diagnosis and treatment of pyruvate kinase deficiency]

    Zhonghua Yi Xue Za Zhi
    |December 2, 2024
    PubMed

    Insights

    Pyruvate kinase deficiency (PKD) is a rare genetic disorder affecting red blood cells. This consensus provides guidance on diagnosing and managing PKD, including its complications and treatment.

    Area of Science:

    • Genetics and Molecular Biology
    • Hematology
    • Metabolic Disorders

    Context:

    • Pyruvate kinase deficiency (PKD) is a rare autosomal recessive disorder.
    • Mutations in the PKLR gene impair erythrocyte energy production.
    • This leads to chronic hemolytic anemia and related complications.

    Purpose:

    • To provide a comprehensive consensus on PKD.
    • To guide clinicians in diagnosis, treatment, and complication management.
    • To improve medical services for patients with pyruvate kinase deficiency.

    Summary:

    • Focuses on the pathogenesis, clinical characteristics, diagnosis, and treatment of PKD.
    • Highlights the need for individualized treatment approaches.
    • Covers complications like iron overload and cardiopulmonary issues.

    Impact:

    • Aims to enhance the medical care provided to PKD patients.
    • Offers a valuable resource for clinicians managing this rare condition.
    • Contributes to better monitoring and prevention strategies for PKD complications.